-
MSI’s 2023 Impact Brief
In 2023, MSI delivered reproductive healthcare to 93,000 women and girls every day — giving them the power to choose their own futures. Read more about MSI’s 2023 impact.
-
Briefing: Choice and the Climate Crisis
MSI works in climate-affected communities around the world to ensure that women’s reproductive health services are available wherever possible. Find out more in our short brief.
-
Briefing: Choice on the Ballot
2024 is the biggest election year in history, with at least 64 national, presidential, or parliamentary elections taking place around the world. The outcome of these elections will shape the future of sexual and reproductive health and rights for generations to come.
-
New Guttmacher report shows long-term harms of US Global Gag Rule in Ethiopia and Uganda
The Guttmacher Institute today published a multi-year research study which reveals the U.S. Global Gag Rule (GGR) disrupted critical health services affecting women and girls in Uganda and Ethiopia – two countries that rely on U.S. assistance for their family planning programmes.
-
Advocacy win: Mifepristone registered in Tanzania
MSI and partners have successfully advocated to have mifepristone – the second of two medications used for abortion and post-abortion care – registered and authorised for use in Tanzania.
-
MSI meets with Canadian Officials to discuss commitment to choice
From 25-27th March, MSI was proud to meet with Canadian Officials and Global Affairs Canada, to discuss the incredible impact Canada is making on health, lives, and futures around the world, with their support for reproductive choice.
-
Digital Disparities: The global battle for reproductive rights on social media
Our report with the Centre for Countering Digital Hate finds that Meta and Google are blocking access to accurate information on abortion and wider reproductive healthcare in countries across Africa, Asia, and Latin America.
-
Press Release: Meta and Google restrict access to reproductive health information
New report: Meta and Google restrict access to reproductive health information in Africa, Asia, and Latin America – while enabling misinformation and abuse.
-
Resources on delivering reproductive healthcare (WISH programme)
Five years worth of insights, evidence and learnings from delivering WISH programme in Africa. We share toolkits, trainings and resources for the health sector.
-
MSI Statement on U.S. Supreme Court Hearing on Mifepristone
The Supreme Court of the United States will hear oral arguments around access to mifepristone, an essential abortion medication that is used by more than 5 million people in the US. Read our statement.
-
Webinar: Achieving value for money reproductive health programmes
MSI recently hosted a webinar discussion on how to achieve and measure value for money in sexual and reproductive health programmes.